Literature DB >> 10901378

Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method.

E Smid-Koopman1, L J Blok, S Chadha-Ajwani, T J Helmerhorst, A O Brinkmann, F J Huikeshoven.   

Abstract

The recently developed cDNA expression array technique can be used to generate gene-expression fingerprints of tumour specimens. To gain insight into molecular mechanisms involved in the development and progression of cancer, this cDNA expression array technique could be a useful tool, however, no established methods for interpreting the results are yet available. We used the Atlas cancer cDNA expression array (Clontech, USA) for analysing total RNA isolated from four human endometrial carcinoma samples (two cell-lines and two tissue samples), one benign endometrial tissue sample and a human breast cancer cell-line, in order to develop a method for analysing the array data. The obtained gene-expression profiles were highly reproducible. XY-scatterplots and regression analysis of the logarithmic transformed data provided a practical method to analyse the data without the need of preceding normalization. Three genes (Decorin, TIMP3 and Cyclin D1) were identified to be differentially expressed between the benign endometrial tissue sample and the endometrial carcinoma samples (tissue and cell-lines). These three genes may potentially be involved in cancer progression. A higher degree of similarity in gene-expression profile was found between the endometrial samples (tissue and cell-lines) than between the endometrial samples and the breast cancer cell-line, which is indicative for an endometrial tissue-specific gene-expression profile.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901378      PMCID: PMC2363496          DOI: 10.1054/bjoc.2000.1238

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array.

Authors:  C Shim; W Zhang; C H Rhee; J H Lee
Journal:  Clin Cancer Res       Date:  1998-12       Impact factor: 12.531

2.  CDK-independent activation of estrogen receptor by cyclin D1.

Authors:  R M Zwijsen; E Wientjens; R Klompmaker; J van der Sman; R Bernards; R J Michalides
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

Review 3.  Endometrial carcinoma.

Authors:  P G Rose
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

4.  Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.

Authors:  G T Chang; L J Blok; M Steenbeek; J Veldscholte; W M van Weerden; G J van Steenbrugge; A O Brinkmann
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

5.  All in the (cancer) family.

Authors:  A G Knudson
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

Review 6.  Advanced and recurrent endometrial carcinoma: hormonal therapy.

Authors:  S S Lentz
Journal:  Semin Oncol       Date:  1994-02       Impact factor: 4.929

Review 7.  Epidemiology of endometrial neoplasia.

Authors:  D Schottenfeld
Journal:  J Cell Biochem Suppl       Date:  1995

8.  Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation.

Authors:  L J Blok; M E Grossmann; J E Perry; D J Tindall
Journal:  Mol Endocrinol       Date:  1995-11

9.  Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.

Authors:  H Sato; Y Kida; M Mai; Y Endo; T Sasaki; J Tanaka; M Seiki
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

10.  Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.

Authors:  L J Blok; G T Chang; M Steenbeek-Slotboom; W M van Weerden; H G Swarts; J J De Pont; G J van Steenbrugge; A O Brinkmann
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

View more
  11 in total

1.  Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.

Authors:  Bethany L V Cuetara; Tania N Crotti; Anthony J O'Donoghue; Kevin P McHugh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

Review 2.  Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.

Authors:  Mukesh Verma; Daniela Seminara; Fernando J Arena; Christy John; Kumiko Iwamoto; Virginia Hartmuller
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Decorin is responsible for progression of non-small-cell lung cancer by promoting cell proliferation and metastasis.

Authors:  Xuefei Shi; Wenjun Liang; Wen Yang; Rui Xia; Yong Song
Journal:  Tumour Biol       Date:  2014-12-20

4.  microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.

Authors:  Eric J Devor; Adriann M Hovey; Michael J Goodheart; Shyam Ramachandran; Kimberly K Leslie
Journal:  Oncol Rep       Date:  2011-07-01       Impact factor: 3.906

5.  Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells.

Authors:  Marie C Nyman; Anne B Jokilammi; Pia C Boström; Samu H Kurki; Annele O Sainio; Seija E Grenman; Katri J Orte; Sakari H Hietanen; Klaus Elenius; Hannu T Järveläinen
Journal:  J Histochem Cytochem       Date:  2019-04-22       Impact factor: 2.479

6.  TIMP-3 and Phosphatidylinositol 3-kinase genes were found to be related to the progression of colon cancer in a comparison of pneumoperitoneum and laparotomy in a murine model.

Authors:  Fumiaki Tanaka; Hideto Sonoda; Masahiro Okamoto; Koshi Mimori; Tohru Utsunomiya; Hiroshi Inoue; Taizo Hanai; Masaki Mori
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

Review 7.  Progress in the application of DNA microarrays.

Authors:  E K Lobenhofer; P R Bushel; C A Afshari; H K Hamadeh
Journal:  Environ Health Perspect       Date:  2001-09       Impact factor: 9.031

8.  In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer.

Authors:  Samir A Saidi; Cathrine M Holland; D Stephen Charnock-Jones; Stephen K Smith
Journal:  Mol Cancer       Date:  2006-03-28       Impact factor: 27.401

9.  Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.

Authors:  A D Santin; F Zhan; S Cane'; S Bellone; M Palmieri; M Thomas; A Burnett; J J Roman; M J Cannon; J Shaughnessy; S Pecorelli
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

10.  The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor.

Authors:  Katie A Ashton; Anthony Proietto; Geoffrey Otton; Ian Symonds; Mark McEvoy; John Attia; Michael Gilbert; Ute Hamann; Rodney J Scott
Journal:  BMC Cancer       Date:  2008-09-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.